Reuters: Regulatory News: CORRECTED-Covidien recalls some prefill flush syringes

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

50% off Print Subscription of USA Today Get the news delivered to your doorstep. Lock in the savings and receive USA Today for just $0.75 a day. From our sponsors

CORRECTED-Covidien recalls some prefill flush syringes Aug 20th 2013, 17:11 Tue Aug 20, 2013 1:11pm EDT Aug 19 (Reuters) - Medical device maker Covidien Plc said it was recalling six lots of its Monoject prefill flush syringes sold in the United States and Bermuda as they contained non-sterilized water which could cause life-threatening infections. Some of the syringes, meant to administer saline or anti-clotting drug heparin, also had mismatched caps, labels and wrappers, the company said. (link.reuters.com/jag52v) The syringes are used to reduce blood clots in veins and remove medication left at catheter sites. Using the heparin syringe containing only water could cause clotting in catheters. (Reporting By Vrinda Manocha in Bangalore; Editing by Don Sebastian)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions